Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis

To characterize long-term repopulation of peripheral immune cells following alemtuzumab-induced lymphopenia in relapsing-remitting MS (RRMS), with a focus on regulatory cell types, and to explore associations ...

Source: Journal of Neuroinflammation - June 15, 2020 Category: Neurology Authors: Wendy Gilmore, Brett T. Lund, Peili Li, Alex M. Levy, Eve E. Kelland, Omid Akbari, Susan Groshen, Steven Yong Cen, Daniel Pelletier, Leslie P. Weiner, Adil Javed, Jeffrey E. Dunn and Anthony L. Traboulsee Tags: Research Source Type: research